REG - Craneware plc - Transaction in Own Shares

CranewareAnnouncement

Yesterday 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260512:nRSL8744Da&default-theme=true

RNS Number : 8744D  Craneware plc  12 May 2026

12 May 2026

 

Craneware plc

 ("Craneware", or the "Company")

 Transaction in Own Shares

 

Craneware (AIM: CRW.L), a leader in healthcare financial performance
solutions, announces it has purchased the following number of its Ordinary
Shares of 1p each through Joh. Berenberg, Gossler & Co. KG, London Branch
("Berenberg") on the London Stock Exchange.

 

 Date of purchases:                                   05 to 11 May 2026
 Aggregate number of Ordinary Shares purchased:                        193,334
 Lowest price paid per share (GBp):                                   1,532.94
 Highest price paid per share (GBp):                                  1,606.00
 Volume weighted average price paid per share (GBp):                  1,563.05

The Company will hold the purchased shares in Treasury. Following the purchase
of these shares, the Company will have 34,280,282 Ordinary Shares in issue
(excluding Treasury shares), and the Company will hold 1,261,887 Ordinary
Shares in Treasury.

 

The figure of 34,280,282 represents the total voting rights in the Company and
may be used by shareholders as the denominator for calculating whether they
are required to notify their interest in, or a change to their interest in,
the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

The table below contains detailed information about the purchases made as part
of the buyback programme which was announced by the Company on 16 March 2026
(the "Programme").

 

Schedule of Purchases - Individual Transactions

 

In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No
596/2014 as it forms part of UK law, a full breakdown of the individual trades
made by Berenberg on behalf of the Company as part of the Programme is
detailed below:

 

 Number of ordinary shares purchased  Transaction price (GBp share)  Time of transaction (UK Time)  Transaction        Trading Venue

                                                                                                    reference number

 2,500                                1538.00                        05.05.2026 08:41:32            00066949098TRLO1   LSE
 3,000                                1534.38                        05.05.2026 10:34:38            00066958639TRLO1   LSE
 5,000                                1550.00                        05.05.2026 10:52:48            00066961789TRLO1   LSE
 2,500                                1578.00                        05.05.2026 12:21:34            00066969108TRLO1   LSE
 12,500                               1574.59                        05.05.2026 14:09:02            00066978152TRLO1   LSE
 9,500                                1575.00                        05.05.2026 14:09:15            00066978170TRLO1   LSE
 10,800                               1575.00                        05.05.2026 14:10:25            00066978265TRLO1   LSE
 2,500                                1606.00                        06.05.2026 13:05:00            00067035183TRLO1   LSE
 2,500                                1551.00                        06.05.2026 08:30:00            00067012757TRLO1   LSE
 7,500                                1600.00                        06.05.2026 09:51:00            00067019100TRLO1   LSE
 34,307                               1605.28                        06.05.2026 13:54:00            00067037641TRLO1   LSE
 5,500                                1555.16                        07.05.2026 14:01:00            00067149776TRLO1   LSE
 4,000                                1558.99                        08.05.2026 09:39:56            00067309800TRLO1   LSE
 5,000                                1551.18                        08.05.2026 13:28:36            00067318129TRLO1   LSE
 38,317                               1548.19                        08.05.2026 15:49:25            00067330339TRLO1   LSE
 1,000                                1537.96                        11.05.2026 09:48:00            00067346722TRLO1   LSE
 1,500                                1546.00                        11.05.2026 10:14:00            00067347379TRLO1   LSE
 2,000                                1545.23                        11.05.2026 11:22:00            00067349157TRLO1   LSE
 7,500                                1539.33                        11.05.2026 12:33:00            00067351265TRLO1   LSE
 4,250                                1535.00                        11.05.2026 13:57:00            00067354195TRLO1   LSE
 12,000                               1533.94                        11.05.2026 15:19:00            00067362127TRLO1   LSE
 19,660                               1532.94                        11.05.2026 15:30:00            00067363698TRLO1   LSE

 

For further information please contact:

 

Craneware
plc
+44 (0)131 550 3100

Keith Neilson, CEO

Craig Preston, CFO

 

Alma Strategic
Communications
 
                +44 (0)20 3405 0205

Caroline Forde, Kinvara Verdon, Louisa
El-Ahwal
craneware@almastrategic.com

 

About Craneware

 

For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in
healthcare financial and operational transformation, delivering cutting-edge
technologies that drive measurable impact. Our Trisus® cloud ecosystem
unifies data, revenue intelligence, margin intelligence, and advanced
analytics, enabling healthcare organizations to optimize performance, improve
financial sustainability, and drive strategic growth. As a trusted Microsoft
partner, we provide future-ready solutions-including the Best in KLAS Trisus
Chargemaster - that simplify the complexities of healthcare finance and
operations. What sets us apart is our unique combination of deep healthcare
expertise and engineering excellence, positioning us as a strategic partner
rather than just a technology provider. The Craneware Group empowers
healthcare organizations to achieve sustainable financial success while
delivering better outcomes for the communities they serve - today and in the
future. Together, we are transforming the business of healthcare.

 

Learn more at www.thecranewaregroup.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  POSGPUQAAUPQGBG



            Copyright 2019 Regulatory News Service, all rights reserved